Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrastromal Anti-VEGF Injection for Corneal Neovascularization
NCT07329686Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of anti-VEGF intravitreal injection in Herpes simplex keratitis, corneal neovascularization (CNV), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Oct 2025; status: recruiting.
02
Drugs
anti-VEGF intravitreal injection
03
Conditions
Herpes simplex keratitiscorneal neovascularization (CNV)
Beyond the preview
Go deeper on NCT07329686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07329686.